AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting

Executive Summary

• AI/ML Innovations Inc. (AIML) announced that its subsidiary NeuralCloud Solutions will launch a multi‑stage pilot of the CardioYield™ AI‑powered Holter ECG analysis platform with a major Canadian cardiology clinic network.
• The pilot will progress from internal data validation to in‑clinic testing and eventual full integration, pending Health Canada Class II medical device clearance.
• The partner clinics perform >1,000 Holter assessments per month, providing a sizable dataset to benchmark improvements in workflow efficiency and diagnostic accuracy.

Key Details

• Collaboration Scope: Multi‑stage pilot – internal validation → clinic‑site pilot → full integration of CardioYield™ reporting interface and MaxYield signal‑enhancement neural network.
• Technology: AI‑driven ECG denoising, automated labeling, structured Holter report generation; marketed as CardioYield™ powered by MaxYield™.
• Regulatory Path: Commercial rollout contingent on Health Canada Class II Software as a Medical Device clearance.
• Partner Profile: Confidential full‑service cardiology network with multiple locations across Canada; conducts >1,000 Holter studies monthly.
• Strategic Goal: Modernize Holter ECG reporting workflow, increase throughput, and improve diagnostic precision for the clinic partner.
• Quotes:
• Paul Duffy, CEO – emphasizes mission to deliver AI‑driven healthcare solutions and anticipated impact on clinical efficiency and accuracy.
• Esmat Naikyar, President of NeuralCloud Solutions & CPO of AIML – highlights step forward in bringing AI‑enhanced cardiac reporting into practice and potential reduction in analysis time.
• Future Disclosure: Identity of the clinic partner will remain confidential until mutually agreed public announcement.

Notable Quotes

“CardioYield is built to improve both clinical efficiency and diagnostic accuracy, and we look forward to demonstrating its impact in collaboration with a leading cardiac care provider.” – Paul Duffy, CEO, AIML

“This collaboration marks an important step forward in bringing our AI‑enhanced cardiac reporting technology into clinical practice… AI can meaningfully reduce analysis time and improve the reliability of ECG interpretation.” – Esmat Naikyar, President, NeuralCloud Solutions & CPO, AIML